+499.5%
MRNA vs ED
+12.4%
+487.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ED | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.3% | -0.9% | -2.9% |
| 7D | +5.5% | -0.2% | +5.7% | +5.4% |
| 30D | +158.7% | -0.1% | +158.9% | +158.8% |
| 3M | +182.1% | +3.9% | +178.2% | +184.1% |
| 6M | +151.8% | -3.0% | +154.9% | +154.5% |
| YTD | +393.6% | +10.7% | +382.9% | +377.3% |
| 1Y | +499.5% | +13.3% | +486.1% | +488.4% |
| All | +499.5% | +12.4% | +487.0% | +488.4% |
Cumulative growth
Daily Returns
Daily percentage return beside ED.
Daily Out/Under-Performance
Portfolio return minus ED return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ED return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ED wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling